Credit: Getty Images. The SC formulation is intended to be administered in 10 minutes twice a year. Positive data were announced from a phase 3 trial evaluating an investigational subcutaneous (SC) ...
Credit: Thinkstock. The randomized, double-blind, double-dummy, active-controlled study compared ABBV-951 via continuous SC infusion to oral levodopa/carbidopa. Positive results were announced from a ...
A COVID-19 therapy that might be able to help high-risk patients stay healthy enough to avoid a hospital visit is rolling out at South Carolina hospitals, though the drug is unapproved and its ...
Patients should receive training on the proper use of the delivery device prior to starting treatment. The Food and Drug Administration (FDA) has approved Onapgo™ (apomorphine hydrochloride [HCl]) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback